{"title":"Transperitoneal Versus Extraperitoneal Approach for Laparoscopic and Robot-Assisted Radical Prostatectomy: A Systematic Review and Meta-Analysis.","authors":"Stefanus Purnomo, Agus Rizal Ardy Hariandy Hamid, Moammar Andar Roemare Siregar, Andika Afriansyah, Hendy Mirza, Doddy Hami Seno, Nugroho Purnomo","doi":"10.5152/tud.2023.23008","DOIUrl":null,"url":null,"abstract":"<p><p>To conduct a comparative analysis of outcomes from 2 different surgical approaches, transperitoneal radical prostatectomy (TP-RP) and extraperitoneal radical prostatectomy (EP-RP) in minimally invasive surgery. A comprehensive search was conducted up to September 2022 using 5 online databases, namely PubMed, Cochrane, Scopus, EMBASE, and Science Direct. Studies were screened per the eligibility criteria, and outcomes included operative duration, estimated blood loss (EBL), hospital stay, operative complication, and positive surgical margin. Total of 13 studies compiled of 2387 patients were selected, with TP-RP and EP-RP performed on 1117 (46.79%) and 1270 (53.21%) patients, respectively. Six laparoscopy radical prostatectomy (LRP) studies and 7 robotassisted radical prostatectomy (RARP) studies with 1140 and 1247 patients, respectively, were also included. The EP-RP demonstrated a marked advantage in terms of operative complications (Risk Ratio [RR]=0.78, 95% CI=0.62, 0.98; P=.04), but no significant difference concluded for operative duration, EBL, hospital stay, and surgical margin. In the RARP group, there was a significant difference in operative duration for EP-RARP and TP-RARP (Mean difference [MD]=-17.27, 95% CI=-26.89, -7.65; P=.0004), hospital stay (MD=-0.54, 95% CI=-0.94, -0.14; P=.008), and operative complications (RR=0.7, 95% CI=0.49, 0.99; P=.04). There were no noteworthy variations identified in EBL and surgical margin. Furthermore, the LRP group did not show any significant differences. This study shows that regardless of the techniques used, EP-RP has a lower risk of operative complications than TP-RP, with no significant difference in other outcomes.</p>","PeriodicalId":101337,"journal":{"name":"Urology research & practice","volume":"49 5","pages":"285-292"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646806/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology research & practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5152/tud.2023.23008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
To conduct a comparative analysis of outcomes from 2 different surgical approaches, transperitoneal radical prostatectomy (TP-RP) and extraperitoneal radical prostatectomy (EP-RP) in minimally invasive surgery. A comprehensive search was conducted up to September 2022 using 5 online databases, namely PubMed, Cochrane, Scopus, EMBASE, and Science Direct. Studies were screened per the eligibility criteria, and outcomes included operative duration, estimated blood loss (EBL), hospital stay, operative complication, and positive surgical margin. Total of 13 studies compiled of 2387 patients were selected, with TP-RP and EP-RP performed on 1117 (46.79%) and 1270 (53.21%) patients, respectively. Six laparoscopy radical prostatectomy (LRP) studies and 7 robotassisted radical prostatectomy (RARP) studies with 1140 and 1247 patients, respectively, were also included. The EP-RP demonstrated a marked advantage in terms of operative complications (Risk Ratio [RR]=0.78, 95% CI=0.62, 0.98; P=.04), but no significant difference concluded for operative duration, EBL, hospital stay, and surgical margin. In the RARP group, there was a significant difference in operative duration for EP-RARP and TP-RARP (Mean difference [MD]=-17.27, 95% CI=-26.89, -7.65; P=.0004), hospital stay (MD=-0.54, 95% CI=-0.94, -0.14; P=.008), and operative complications (RR=0.7, 95% CI=0.49, 0.99; P=.04). There were no noteworthy variations identified in EBL and surgical margin. Furthermore, the LRP group did not show any significant differences. This study shows that regardless of the techniques used, EP-RP has a lower risk of operative complications than TP-RP, with no significant difference in other outcomes.
对微创手术中两种不同手术方法的结果进行比较分析,即腹膜外前列腺根治术(TP-RP)和腹膜外前列腺切除术(EP-RP)。截至2022年9月,使用PubMed、Cochrane、Scopus、EMBASE和Science Direct 5个在线数据库进行了全面搜索。根据合格标准对研究进行筛选,结果包括手术持续时间、估计失血量(EBL)、住院时间、手术并发症和阳性手术切缘。共选择了13项研究,共2387名患者,分别对1117名(46.79%)和1270名(53.21%)患者进行了TP-RP和EP-RP。还包括6项腹腔镜根治性前列腺切除术(LRP)研究和7项机器人辅助根治性前列腺摘除术(RARP)研究,分别涉及1140名和1247名患者。EP-RP在手术并发症方面表现出显著优势(风险比[RR]=0.78,95%CI=0.62,0.98;P=0.04),但在手术持续时间、EBL、住院时间和手术切缘方面没有显著差异。在RARP组中,EP-RARP和TP-RARP的手术持续时间存在显著差异(平均差异[MD]=-17.27,95%CI=-26.89,-7.65;P=0.004)、住院时间(MD=-0.54,95%CI=-0.94,-0.14;P=0.008)和手术并发症(RR=0.7,95%CI=0.49,0.99;P=0.04)。此外,LRP组没有显示出任何显著差异。这项研究表明,无论使用何种技术,EP-RP的手术并发症风险都低于TP-RP,其他结果没有显著差异。